biopharm, what is comical is that the bavituximab combination group is performing as expectedoes not mean anything right now. Our phase III which was our path to the market and rvenue was stopped. In the drug business getting drugs approved take years and we are back to square one. We can spin this fact over and over but reality is reality. The management and BOD are making 6 figure incomes and are in no harry for you and I to make any money after 16 years
You guys didn't remember what I said many times before: NO Approval or Partnership = No Rise in Share Price
Market Data 
Markets 
AI
